Conventional High-Dose vs Low-Dose Hyaluronidase for Skin Necrosis after Hyaluronic Acid Fillers: A Systematic Review and Pilot Meta-Analysis
Aesthetic Plastic Surgery · 2024-10 · 48 (19) · 3971-3978
DOI: 10.1007/s00266-024-04334-1 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Aesthetic Plastic Surgery, online erschienen am 30.08.2024. Verfasst von Justin Jia Jun Boey und 3 weiteren Autor:innen. Beteiligte Einrichtung: , Singapore, Singapore. Hauptthemen laut MEDLINE: Cosmetic Techniques, Dermal Fillers, Hyaluronic Acid, Hyaluronoglucosaminidase. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Hyaluronidase remains the mainstay treatment for skin necrosis due to vascular occlusion after hyaluronic acid (HA) dermal fillers. There is wide variability in protocols for the administration of hyaluronidase. Most protocols, however, lack strong evidence regarding hyaluronidase dosages. METHODS: We conducted a systematic review and pilot meta-analysis, searching four international databases from inception until December 2023 for clinical studies reporting on two or more patients receiving hyaluronidase for skin necrosis after hyaluronic acid fillers. Random-effects (DerSimonian and Laird) meta-analyses were conducted. The primary outcome was the pooled proportion of complete scar resolution. We rated intra-study risk of bias using the Joanna Briggs Institute checklists and assessed the certainty of evidence using the GRADE approach. RESULTS: We included 15 studies totaling 223 patients. The pooled proportion of complete scar resolution after hyaluronidase administration was 77.8% (95%-CI: 65.5% to 86.6%, pegger = 0.093, low certainty). Patients treated with high doses of hyaluronidase (>500 international units [IUs]) had lower rates of resolution of 69.6% (95%-CI: 41.2% to 88.3%) compared to those treated with low doses (500IU or less) that had 88.1% rate of resolution (95%-CI: 86.0% to 96.2%), though not statistically significant (p= 0.18). The use of adjunct therapies did not have a statistically significant effect on outcomes. CONCLUSION: A higher proportion of patients receiving low doses (500IU or less) (88.1%) had complete scar resolution compared to patients receiving high doses (69.7%), though not statistically significant (p=0.18). Future studies should provide more granular details on their protocols to benefit the formulation of evidence-based guidelines in future. LEVEL OF EVIDENCE I: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 . PROTOCOL REGISTRATION: CRD42024538661.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- , Singapore, Singapore.
- Dermatology Service, Department of General Medicine, Sengkang General Hospital, Singapore, Singapore.
- Department of Plastic and Reconstructive Surgery, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. zhiyang.ng@gmail.com.
ORCID-Profile: Jonathan Jia En Boey, Taige Cao, Zhi Yang Ng
Zitieren
APA
Boey, J. J. J., Boey, J. J. E., Cao, T., & Ng, Z. Y. (2024). Conventional High-Dose vs Low-Dose Hyaluronidase for Skin Necrosis after Hyaluronic Acid Fillers: A Systematic Review and Pilot Meta-Analysis. Aesthetic Plastic Surgery, 48(19), 3971-3978. https://doi.org/10.1007/s00266-024-04334-1
Vancouver
Boey JJJ, Boey JJE, Cao T, Ng ZY. Conventional High-Dose vs Low-Dose Hyaluronidase for Skin Necrosis after Hyaluronic Acid Fillers: A Systematic Review and Pilot Meta-Analysis. Aesthetic Plastic Surgery. 2024;48(19):3971-3978. doi:10.1007/s00266-024-04334-1
BibTeX
@article{Boey2024,
author = {Boey, Justin Jia Jun and Boey, Jonathan Jia En and Cao, Taige and Ng, Zhi Yang},
title = {Conventional High-Dose vs Low-Dose Hyaluronidase for Skin Necrosis after Hyaluronic Acid Fillers: A Systematic Review and Pilot Meta-Analysis},
journal = {Aesthetic Plastic Surgery},
year = {2024},
volume = {48},
number = {19},
pages = {3971--3978},
doi = {10.1007/s00266-024-04334-1}
}
EUVIMED